These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 21858415)

  • 21. Postoperative concomitant irradiation and chemotherapy with mitomycin C and bleomycin for advanced head-and-neck carcinoma.
    Smid L; Budihna M; Zakotnik B; Soba E; Strojan P; Fajdiga I; Zargi M; Oblak I; Dremelj M; LeSnicar H
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1055-62. PubMed ID: 12829141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Factors After Definitive Radio(Chemo)Therapy of Locally Advanced Head and Neck Cancer.
    Seidl D; Janssen S; Strojan P; Bajrovic A; Schild SE; Rades D
    Anticancer Res; 2016 May; 36(5):2523-6. PubMed ID: 27127167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of treatment outcomes by radiochemotherapy and postoperative radiotherapy in locally advanced squamous cell carcinomas of head and neck.
    Fortin A; Caouette R; Wang CS; Vigneault E
    Am J Clin Oncol; 2008 Aug; 31(4):379-83. PubMed ID: 18845998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial.
    Tobias JS; Monson K; Gupta N; Macdougall H; Glaholm J; Hutchison I; Kadalayil L; Hackshaw A;
    Lancet Oncol; 2010 Jan; 11(1):66-74. PubMed ID: 19875337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of outcome in patients with metastatic cutaneous head and neck squamous cell carcinoma involving cervical lymph nodes: Improved survival with the addition of adjuvant radiotherapy.
    Wang JT; Palme CE; Morgan GJ; Gebski V; Wang AY; Veness MJ
    Head Neck; 2012 Nov; 34(11):1524-8. PubMed ID: 22109745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic impact of VEGF and VEGF receptor 1 (FLT1) expression in patients irradiated for stage II/III non-small cell lung cancer (NSCLC).
    Rades D; Setter C; Dunst J; Dahl O; Schild SE; Noack F
    Strahlenther Onkol; 2010 Jun; 186(6):307-14. PubMed ID: 20437013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm.
    Pfister DG; Su YB; Kraus DH; Wolden SL; Lis E; Aliff TB; Zahalsky AJ; Lake S; Needle MN; Shaha AR; Shah JP; Zelefsky MJ
    J Clin Oncol; 2006 Mar; 24(7):1072-8. PubMed ID: 16505426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic implications of hemoglobin levels before and after surgery as well as before and after radiochemotherapy for head and neck tumors.
    Reichel O; Panzer M; Wimmer C; Dühmke E; Kastenbauer E; Suckfüll M
    Eur Arch Otorhinolaryngol; 2003 May; 260(5):248-53. PubMed ID: 12750913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer.
    Lavertu P; Bonafede JP; Adelstein DJ; Saxton JP; Strome M; Wanamaker JR; Eliachar I; Wood BG
    Arch Otolaryngol Head Neck Surg; 1998 Apr; 124(4):401-6. PubMed ID: 9559686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined neck dissection and postoperative radiation therapy in the management of the high-risk neck: a matched-pair analysis.
    Lundahl RE; Foote RL; Bonner JA; Suman VJ; Lewis JE; Kasperbauer JL; McCaffrey TV; Olsen KD
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):529-34. PubMed ID: 9486600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Taxane, platinum and 5-FU prior to chemoradiotherapy benefits patients with stage IV neck node-positive head and neck cancer and a good performance status.
    Lowe NM; Bernstein JM; Mais K; Garcez K; Lee LW; Sykes A; Thomson DJ; Homer JJ; West CM; Slevin NJ
    J Cancer Res Clin Oncol; 2018 Feb; 144(2):389-401. PubMed ID: 29222650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distant metastases in head-and-neck squamous cell carcinoma treated with intensity-modulated radiotherapy.
    Yao M; Lu M; Savvides PS; Rezaee R; Zender CA; Lavertu P; Buatti JM; Machtay M
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):684-9. PubMed ID: 22169673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
    Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
    Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.
    Bonner JA; Harari PM; Giralt J; Cohen RB; Jones CU; Sur RK; Raben D; Baselga J; Spencer SA; Zhu J; Youssoufian H; Rowinsky EK; Ang KK
    Lancet Oncol; 2010 Jan; 11(1):21-8. PubMed ID: 19897418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radio(chemo)therapy in the management of squamous cell carcinoma of cervical lymph nodes from an unknown primary site. A retrospective analysis.
    Fakhrian K; Thamm R; Knapp S; Molls M; Pigorsch S; Haller B; Geinitz H
    Strahlenther Onkol; 2012 Jan; 188(1):56-61. PubMed ID: 22189437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience.
    Nguyen-Tan PF; Le QT; Quivey JM; Singer M; Terris DJ; Goffinet DR; Fu KK
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1172-80. PubMed ID: 11483326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radio(chemo)therapy plus resection versus radio(chemo)therapy alone for the treatment of stage III esophageal cancer.
    Rades D; Schulte R; Yekebas EF; Homann N; Schild SE; Dunst J
    Strahlenther Onkol; 2007 Jan; 183(1):10-6. PubMed ID: 17225940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgery with postoperative radiotherapy for pN2 head and neck squamous cell carcinoma.
    Joo YH; Cho KJ; Park JO; Nam IC; Kim CS; Cho HJ; Kim MS
    Acta Otolaryngol; 2013 Oct; 133(10):1104-9. PubMed ID: 24032573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the prognostic role of tumor cell podoplanin expression in locally advanced squamous cell carcinoma of the head and neck.
    Huttenlocher S; Seibold ND; Gebhard MP; Noack F; Thorns C; Hasselbacher K; Wollenberg B; Schild SE; Rades D
    Strahlenther Onkol; 2014 Oct; 190(11):1021-7. PubMed ID: 24928249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers.
    Salama JK; Haraf DJ; Stenson KM; Blair EA; Witt ME; Williams R; Kunnavakkam R; Cohen EE; Seiwert T; Vokes EE
    Ann Oncol; 2011 Oct; 22(10):2304-9. PubMed ID: 21330337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.